GSK plc (FRA:GS71)

Market Cap	62.66B
Revenue (ttm)	37.69B
Net Income (ttm)	3.77B
Shares Out	n/a
EPS (ttm)	0.91
PE Ratio	16.63
Forward PE	7.93
Dividend	0.74 (4.72%)
Ex-Dividend Date	May 15, 2025

Volume	120,973
Average Volume	475,283
Open	15.56
Previous Close	15.58
Day's Range	15.49 - 15.75
52-Week Range	14.49 - 19.97
Beta	n/a
RSI	32.45
Earnings Date	Jul 28, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 68,629
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GS71

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP